CFO SpotlightsCareers of chief financial officers, from the filings. Records as of October 28, 2026

  1. CFO Spotlights
  2. Profiles
  3. Sean Bohen, M.D., Ph.D.

Profile

Sean Bohen, M.D., Ph.D.

President, Chief Executive Officer and Director ( Principal Executive Officer and Principal Financial Officer ), Olema Pharmaceuticals, Inc.

A later filing names a successor. First published here October 28, 2026; built from records as of October 28, 2026.

Sean Bohen, M.D., Ph.D. signed the annual report of Olema Pharmaceuticals, Inc. on Form 10-K as President, Chief Executive Officer and Director ( Principal Executive Officer and Principal Financial Officer ), filed March 16, 2026.1 A later filing by Olema Pharmaceuticals, Inc., made on August 13, 2026, names Jason O'Byrne as its chief financial officer; the record holds no filing that reports the end of Sean Bohen, M.D., Ph.D.'s tenure.

Seats

The seat in the record

CompanyTitle as filedStandingFilings
Olema Pharmaceuticals, Inc. (OLMA)
Pharmaceutical Preparations
President, Chief Executive Officer and Director ( Principal Executive Officer and Principal Financial Officer )A later filing names a successor
Jason O'Byrne, filed August 13, 2026 (filing)
1

Company names link to the company's page in the record at CFO Tribune, which holds the seat history.

The record

Filing by filing, latest first

  1. March 16, 202610-K filed

    Sean Bohen, M.D., Ph.D. signed the annual report of Olema Pharmaceuticals, Inc. on Form 10-K as President, Chief Executive Officer and Director ( Principal Executive Officer and Principal Financial Officer ), filed March 16, 2026.

    /s/ Sean Bohen, M.D., Ph.D. President, Chief Executive Officer and Director March 16, 2026 Sean Bohen, M.D., Ph.D. ( Principal Executive Officer and Principal Financial Officer )

    [1] Annual report on Form 10-K by Olema Pharmaceuticals, Inc., filed with the SEC on March 16, 2026. Read the filing. The record at CFO Tribune.

Sources

Sources

  1. Annual report on Form 10-K, Olema Pharmaceuticals, Inc.. U.S. Securities and Exchange Commission, EDGAR, filed March 16, 2026. sec.gov; record.

Corrections and removal

If a line here is wrong, or Sean Bohen, M.D., Ph.D. wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.